Co-occurring Alcohol and Tobacco/Nicotine Use Disorders

Co-occurring Alcohol and Tobacco/Nicotine Use Disorders

Host: Addiction Technology Transfer Center
Recorded: September 16, 2025
Enduring Training

Overview

This 75-minute discussion uses case-based examples to explore clinical approaches for treating Alcohol Use Disorder (AUD) and Tobacco Use Disorder (TUD) simultaneously. It covers medication options such as Nicotine Replacement Therapy (NRT), bupropion, and varenicline, alongside behavioral strategies like motivational interviewing and counseling techniques to reduce the risk of harm. Special attention is given to the unique needs of patients with serious mental illness when addressing co-occurring AUD and TUD. Learners gain a deeper understanding of anti-craving medications and how to support proper use in diverse patient populations.

This course is eligible for 1 NBCC Contact Hour and 1 NAADAC CE. 

The target audience for this introductory level activity includes: All types of healthcare professionals. 

The ACGME Competencies include: Patient Care and Procedural Skills, Medical Knowledge, and Systems-based Practice

Learning Objectives

Upon completion, learners will be able to:

1. Understand the general approach to integrated treatment of tobacco use disorder (TUD) and other behavioral health conditons.
2. Understand the appraoch to treatment of co-occurring TUD and AUD.
3. Gain a more sophisticated working knowledge of medication treatment approaches for TUD.

Open Registration: 10/13/2025 - 08/30/2027

Close Access Date: 09/30/2027

Instructions

1. Click on the Contents tab to begin this activity.  
2. Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window. 
3. Click Claim Certificate of Completion to view/print certificate.  

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcssmaud@asam.org.

Accreditation & Credit Designation Statements

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

National Board for Certified Counselors ACEP 

This activity offers 1 NBCC Contact Hour(s).

The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

NAADAC, The Association for Addiction Professionals

This course has been approved by the American Society of Addiction Medicine (ASAM) as a NAADAC Approved Education Provider, for 1 CE(s). NAADAC Provider #295, the American Society of Addiction Medicine (ASAM) is responsible for all aspects of its programing.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-0227.

Continuing Education Credits (CEUs)

Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

The following planners have relevant financial relationships:

• Kevin Sevarino, MD, PhD (Advisory Committee/Planner): GlaxoSmithKline, Stockholder

All other planners, faculty, and staff have no relevant financial relationships.

All relevant financial relationships have been identified and mitigated.